IRIS
RAVAGLIA, SABRINA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.672
AS - Asia 1.898
EU - Europa 1.812
SA - Sud America 231
Continente sconosciuto - Info sul continente non disponibili 73
AF - Africa 60
OC - Oceania 6
Totale 6.752
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.621
CN - Cina 891
SG - Singapore 435
IE - Irlanda 372
IT - Italia 319
DE - Germania 229
HK - Hong Kong 221
FI - Finlandia 201
RU - Federazione Russa 189
VN - Vietnam 182
UA - Ucraina 173
BR - Brasile 165
GB - Regno Unito 101
FR - Francia 81
IN - India 37
SE - Svezia 36
ZA - Sudafrica 31
BD - Bangladesh 28
CA - Canada 26
EC - Ecuador 19
BE - Belgio 18
AR - Argentina 17
JP - Giappone 16
NL - Olanda 16
ES - Italia 15
PL - Polonia 14
MX - Messico 13
IQ - Iraq 10
MA - Marocco 10
PK - Pakistan 10
CL - Cile 7
CO - Colombia 7
MY - Malesia 7
AT - Austria 6
CZ - Repubblica Ceca 6
ID - Indonesia 6
LT - Lituania 6
AU - Australia 5
CH - Svizzera 5
KR - Corea 5
SA - Arabia Saudita 5
TN - Tunisia 5
TR - Turchia 5
VE - Venezuela 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
ET - Etiopia 4
GR - Grecia 4
JO - Giordania 4
PE - Perù 4
BH - Bahrain 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KE - Kenya 3
KZ - Kazakistan 3
LB - Libano 3
LU - Lussemburgo 3
PH - Filippine 3
PT - Portogallo 3
PY - Paraguay 3
TH - Thailandia 3
UY - Uruguay 3
AZ - Azerbaigian 2
CR - Costa Rica 2
EG - Egitto 2
JM - Giamaica 2
KH - Cambogia 2
KW - Kuwait 2
NP - Nepal 2
OM - Oman 2
QA - Qatar 2
SK - Slovacchia (Repubblica Slovacca) 2
UZ - Uzbekistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
IR - Iran 1
KG - Kirghizistan 1
MD - Moldavia 1
MK - Macedonia 1
MZ - Mozambico 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
SI - Slovenia 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 6.682
Salva come PNG Salva come JPEG
Città #
Chandler 376
Dublin 369
Singapore 258
San Jose 256
Ashburn 248
Dallas 225
Hong Kong 214
Jacksonville 206
Beijing 188
Nanjing 164
Boardman 121
Helsinki 79
Los Angeles 74
Munich 73
Milan 71
Council Bluffs 70
Ho Chi Minh City 67
Nanchang 60
Lauterbourg 53
Ann Arbor 52
Jiaxing 52
Pavia 52
Changsha 51
Lawrence 50
Princeton 50
Medford 49
Hebei 48
New York 48
Hanoi 44
Shenyang 41
Wilmington 41
Shanghai 35
Buffalo 34
Hangzhou 33
Turku 30
Johannesburg 28
Moscow 28
Tianjin 21
Frankfurt am Main 19
London 18
São Paulo 18
Brussels 17
Redondo Beach 16
Santa Clara 16
Tokyo 16
Orem 14
Trieste 14
Verona 14
Toronto 13
Warsaw 13
Bergamo 12
Brooklyn 12
Rome 12
Turin 11
Amsterdam 10
Columbus 10
Da Nang 10
Seattle 10
The Dalles 10
Woodbridge 10
Atlanta 9
Denver 9
Manchester 9
San Francisco 9
Chicago 8
Houston 8
Cagliari 7
Chennai 7
Dhaka 7
Falkenstein 7
Montreal 7
Nuremberg 7
Piscataway 7
Poplar 7
Pune 7
Stockholm 7
Biên Hòa 6
Charlotte 6
Florence 6
Gorlago 6
Kunming 6
Lahore 6
Lodi 6
Mexico City 6
Modena 6
Naples 6
Norwalk 6
Belo Horizonte 5
Bologna 5
Boston 5
Brno 5
Fairfield 5
Guayaquil 5
Haiphong 5
Monza 5
Quito 5
Travaco Siccomario 5
Zhengzhou 5
Addis Ababa 4
Athens 4
Totale 4.505
Salva come PNG Salva come JPEG
Nome #
Mapping the human genetic architecture of COVID-19 306
A first update on mapping the human genetic architecture of COVID-19 206
A Chaperone Enhances Blood α-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy. 162
Changes in nutritional status and body composition during enzyme replacementtherapy in adult-onset type II glycogenosis. 146
Dietary treatment in adult-onset type II glycogenosis. 140
Adult-onset Alexander disease, associated with a mutation in an alternative GFAP transcript, may be phenotypically modulated by a non-neutral HDAC6 variant. 140
Enzyme replacement therapy (ERT) in adult-onset type II glycogenosis (GSDII) 134
Cognitive impairment and central motor conduction time in chronic alcoholics. 129
Bioimpedance Phase Angle as a Prognostic Tool in Late-Onset Pompe Disease: A Single-Centre Prospective Study With a 15-year Follow-Up 124
Guillain-Barré syndrome associated with SARS-CoV-2 120
Adult-onset type II glycogenosis (GSDII): Clinical spectrum and enzyme replacement therapy (ERT) 119
Severe recurrent myelitis in patients with hepatitis C virus infection 119
Recombinant alpha-glucosidase in adult-onset type II glycogenosis: The experience with the first Italian patient, from expanded access programmes to marketing authorization 119
Clinical MRI dissociation in myelopathy: a clue to sarcoidosis? 119
Early-onset ptosis in type II glycogenosis 118
Aspetti clinici e patogenetici della comorbidita’ emicranica. 118
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patients 117
NMO-IgG-negative relapsing myelitis 116
A genome-wide association study for survival from a multi-centre European study identified variants associated with COVID-19 risk of death 115
COVID-19 in patients with Myasthenia Gravis: epidemiology and disease course 115
Distribution of Exonic Variants in Glycogen Synthesis and Catabolism Genes in Late Onset Pompe Disease (LOPD) 114
Cerebrospinal fluid levels of tau phosphorylated at threonine 181 in patientswith Alzheimer's disease and vascular dementia. 114
The angiotensin-converting enzyme insertion/deletion polymorphysm modifies the clinical outcome in patients with Pompe disease. 111
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response. 111
LOPED study: Looking for an early diagnosis in a late-onset Pompe disease high-risk population 111
Genotype-phenotype correlation in Pompe disease, a step forward. 111
Cytokines and chemokines in cerebrospinal fluid and serum of adult patients with acute disseminated encphalomyelitis. 109
Immune-mediated neuropathies in myeloma patients treated with bortezomib. 107
Diagnosis and therapy of acute disseminated encephalomyelitis and its variants 106
Strabismo parossistico: Meccanismi corticali e meccanismi periferici nella fisiopatologia di due casi con analoga fenomenologia critica 105
Severe recurrent myelitis in patients with hepatitis C virus infection patients 104
Combined central and peripheral demyelination: comparison of adult and pediatric series 104
Enzyme replacement therapy in severe adult-onset glycogen storage disease type II 103
Emicrania emiplegica familiare: dalla genetica alla clinica. 102
Can genes influencing muscle function affect the therapeutic response to enzyme replacement therapy (ERT) in late-onset Type II Glycogenosis? 101
Triggering migraine attacks:the role of nitroderivatives. 101
Efficacy of propafenone in paramyotonia congenita 99
Recombinant alglucosidase alpha (rhGAA) in adult-onset type II glycogenosis (GSDII): A follow-up study before and after treatment 98
Pathogenetic role of myelitis for syringomyelia. 97
Outcome after Two Years of Enzyme Replacement Therapy (ERT) in 29 Patients with Late-Onset Type II Glycogenosis (GSDII) 97
Enzyme replacement therapy in adult-onset type II glycogenosis 92
RECOMBINANT ALGLUCOSIDASE ALFA IN ADULT-ONSET GLYCOGENOSIS TYPE II: A FOLLOW-UP STUDY BEFORE AND AFTER TREATMENT 91
Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease. 90
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 89
Erratum: Spinal hemorrhage in eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (Journal of Neurology (2014) 261 (438-440) DOI: 10.1007/s00415-013-7217-3) 88
Presyrinx in children with Chiari malformations 87
Trunk muscle involvement in late-onset Pompe disease: Study of thirty patients 82
Retinal migraine as unusual feature of cerebral autosomal dominantarteriopathy with subcortical infarcts and leukoencephalopathy(CADASIL) 81
HaNDL syndrome: a reversible cerebral vasoconstriction triggered by an infection? A case report and a case-based review 81
Ocular neuromyotonia with both tonic and paroxysmal components due to vascular compression 80
Enzyme replacement therapy in adult-onset glycogenosis II: Is quantitative muscle MRI helpful? 77
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II. 77
Familial hemiplegic migraine type 2 due to a novel missense mutation in ATP1A2 77
Enzyme replacement therapy in late-onset type II glycogenosis. 76
Erectile dysfunction as a sentinel symptom ofcardiovascular autonomic neuropathy in heavy drinkers 72
The diagnosis of migraine: clinical and instrumental aspects 72
ENZYME REPLACEMENT THERAPY IN LATE-ONSET PHENOTYPES OF GLYCOGENOSIS TYPE 2: RESULTS OF AN ITALIAN MULTICENTER STUDY 70
Post-infectious and postvaccinal acute disseminated encephalomyelitis occurring in the same patients 70
Post-infectious inflammatory disordes:sub-groups based on prospective follow-up. 69
Severe steroid-resistant post-infectious encephalomyelitis: General features and effects of IVIg 69
Enzyme replacement therapy in adult-onset glycogenosis II: is quantitative muscle MRI helpful? 63
COVID-19 and Guillain-Barré syndrome: A single-center prospective case series with a 1-year follow-up 61
Enzyme replacement therapy with Alglucosidase alfa in juvenile-adult glycogenosis type 2 patients 55
Guillain‐Barré syndrome and COVID‐19: A 1‐year observational multicenter study 35
null 34
Quantitative MRI Biomarkers for Early Muscle Involvement in Late Onset Pompe Disease 13
Dynamic MR of Muscle Contraction During Electrical Muscle Stimulation: Potential Application to the Evaluation of Neuromuscular Diseases 6
MYBPC1-associated congenital myopathy with tremor: further delineation of the clinical and pathological phenotype in the first Italian case 5
Dropped Head Syndrome Unmasking Myotonic Dystrophy Type 1 in a Patient with Parkinson's Disease: A Case Report and a Case‐Based Review 3
Totale 6.752
Salva come PNG Salva come JPEG
Categoria #
all - tutte 28.300
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 28.300
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022216 0 3 4 3 0 4 3 11 11 2 36 139
2022/20231.202 84 90 12 174 97 123 2 61 438 13 96 12
2023/2024398 49 73 11 18 28 102 5 26 5 10 19 52
2024/20251.113 34 96 60 31 35 74 68 51 248 42 105 269
2025/20262.343 209 203 260 220 286 109 452 91 232 137 81 63
2026/2027136 45 91 0 0 0 0 0 0 0 0 0 0
Totale 6.752